A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 212
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : Dsg
Long Form : desmoglein
No. Year Title Co-occurring Abbreviation
1993 Cloning of the cDNA (DSC1) coding for human type 1 desmocollin and its assignment to chromosome 18. ---
1993 Contributions of cytoplasmic domains of desmosomal cadherins to desmosome assembly and intermediate filament anchorage. Dsc, IFs
1994 Identification of the plakoglobin-binding domain in desmoglein and its role in plaque assembly and intermediate filament anchorage. Co32
1994 Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins. aa, Dsc
1994 The desmosome and the syndesmos: cell junctions in normal development and in malignancy. Dsc
1995 Continual assembly of half-desmosomal structures in the absence of cell contacts and their frustrated endocytosis: a coordinated Sisyphus cycle. IF
1996 The binding of plakoglobin to desmosomal cadherins: patterns of binding sites and topogenic potential. Dsc, IFs
1997 A YAC contig joining the desmocollin and desmoglein loci on human chromosome 18 and ordering of the desmocollin genes. ---
1997 Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. PF, PV
10  1997 Exon-intron organization of the human type 2 desmocollin gene (DSC2): desmocollin gene structure is closer to "classical" cadherins than to desmogleins. Dsc
11  1997 Expression of desmogleins in Paget cells of mammary and extramammary Paget's disease. EMA, PV
12  1997 Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids. GLA
13  1997 The role of desmoglein 2 and E-cadherin in the invasion and motility of human breast cancer cells. Dsc
14  1998 Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. PNP
15  1998 Desmoglein in multiple self-healing squamous epithelioma of Ferguson-Smith--comparison of staining patterns with actinic keratoacanthoma and squamous cell carcinoma of the skin. KA, MSSE, SCC
16  1998 Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. AK, KA, SCC
17  1998 Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. ---
18  1998 Molecular organization of the desmoglein-plakoglobin complex. C-domain, Dsc
19  1998 The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C. NHEKs, PKC, TPA
20  1999 Diversity of desmosomal proteins in regenerating epidermis: immunohistochemical study using a human skin organ culture model. Dsc
21  1999 Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. PF, PV
22  1999 Internalization of constitutive desmogleins with the subsequent induction of desmoglein 2 in pemphigus lesions. PF, PV
23  1999 Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. PNP
24  1999 Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. Dsg3, IgG, PV
25  1999 Phosphatidylcholine-specific phospholipase C, but not phospholipase D, is involved in pemphigus IgG-induced signal transduction. DAG, P-IgG, PBut, PC, PKC, PLC, PLD
26  1999 The loss of desmosomes after retinoic acid treatment results in an apparent inhibition of HaCaT keratinocyte differentiation. RA
27  2000 A case of pemphigus vulgaris successfully treated with single filtration plasmapheresis: a correlation of clinical disease activity with serum antibody levels. CyA, ELISAs, PSL, PV
28  2000 A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. PV
29  2000 An experience for ELISA for desmoglein 1, suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus. PF, rDsg1
30  2000 Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. PV
31  2000 Different effects of dominant negative mutants of desmocollin and desmoglein on the cell-cell adhesion of keratinocytes. Ad, Dsc
32  2000 Extracellularly truncated desmoglein 1 compromises desmosomes in MDCK cells. DP, Dsc, PG, PPs
33  2000 Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay. BP, ELISPOT, IFN, IL, PBL, PV, Th
34  2000 Identification of desmoglein 1 as autoantigen in a patient with intraepidermal neutrophilic IgA dermatosis type of IgA pemphigus. ELISA, IEN
35  2000 The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. IIF, PV, WB
36  2000 The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus. ELISA, HS, IIF, MO, PF, PV
37  2000 Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. ---
38  2001 A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. PV
39  2001 Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. PNP
40  2001 Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. PF, PV
41  2001 IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris. PV
42  2001 Increased antibody levels to desmogleins 1 and 3 after administration of carbamazepine. ELISA
43  2001 Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. PF, PV
44  2001 The regulatory region of the human desmocollin 3 promoter forms a DNA four-way junction. Dsc
45  2002 IgG/IgA pemphigus with IgG and IgA antidesmoglein 1 antibodies detected by enzyme-linked immunosorbent assay. ---
46  2002 Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris. PV
47  2002 Paraneoplastic pemphigus in children and adolescents. ELISA, IF, PNP
48  2002 The humanized SCID mouse model to study HLA class II-linked autoimmunity to desmoglein 3 in pemphigus vulgaris. PBL, PV
49  2002 The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris. PF, PV
50  2003 Cloning of canine desmoglein 3 and immunoreactivity of serum antibodies in human and canine pemphigus vulgaris with its extracellular domains. IP-IB, PV, RACE, RT-PCR
51  2003 Comparative study of autoantigen profile between Colombian and Brazilian types of endemic pemphigus foliaceus by various biochemical and molecular biological techniques. ELISA, EPF
52  2003 Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. PV
53  2003 Keratinocyte acetylcholine receptors regulate cell adhesion. ATR, CCh, KC, PBr
54  2003 Novel member of the mouse desmoglein gene family: Dsg1-beta. ---
55  2003 Paraneoplastic pemphigus in association with Castleman's disease. IF, IP, PNP
56  2003 T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skin. Ab, PV, Th
57  2004 Desmogleins 1 and 3 in the companion layer anchor mouse anagen hair to the follicle. ETA
58  2004 Genomic organization of mouse desmocollin genes reveals evolutionary conservation. Dsc, IF
59  2004 Mechanisms of blister formation by staphylococcal toxins. ETs
60  2004 Striate palmoplantar keratoderma arising from desmoplakin and desmoglein 1 mutations is associated with contrasting perturbations of desmosomes and the keratin filament network. DP, KIF, SPPK
61  2005 Cloning of swine desmoglein 1 and its direct proteolysis by Staphylococcus hyicus exfoliative toxins isolated from pigs with exudative epidermitis. EE
62  2005 Early detection and successful management of oral pemphigus vulgaris: a case report. ELISA, OST, PV
63  2005 Immunohistochemical analysis of the distribution of desmoglein 1 and 2 in the skin of dogs and cats. ---
64  2005 In vivo ultrastructural localization of the desmoglein 3 adhesive interface to the desmosome mid-line. EC, mAb
65  2005 Intracellular distribution of desmoplakin in human odontoblasts. DPF, DPK, Dsc, JUP, OB
66  2005 Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene: immunohistochemical studies of LEKTI and other epidermal molecules. NS
67  2005 Role of intramolecular epitope spreading in pemphigus vulgaris. PV
68  2005 Three cases of transition from pemphigus vulgaris to pemphigus foliaceus confirmed by desmoglein ELISA. PF, PV
69  2006 A truncated alternative spliced isoform of human desmoglein 1 contains a specific T cell epitope binding to the pemphigus foliaceus-associated HLA class II DRbeta1*0102 molecule. PF
70  2006 Desmoglein autoimmunity in the pathogenesis of pemphigus. ---
71  2006 IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris. IgG, PV
72  2006 Immunoadsorption in pemphigus. CIC, IA
73  2006 Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. PV, Tr1
74  2006 Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line. MAPK, PV
75  2006 Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. PG, PV
76  2006 Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. Dsc, NS, SC, SP
77  2006 Serum autoantibodies to desmogleins 1 and 3 in patients with oral lichen planus. ---
78  2006 Significance of autoimmunity to non-desmoglein targets in pemphigus. KO, PV
79  2006 Transition from pemphigus foliaceus to pemphigus vulgaris: case report with literature review. PF, PV
80  2006 [Desmoglein, the target molecule in autoimmunity and infection]. ---
81  2007 Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus. ---
82  2007 Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus. ELISA, PNP
83  2007 Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. EGF-RK, KCs, PVIgG
84  2007 Dissecting the anti-desmoglein autoreactive B cell repertoire in pemphigus vulgaris patients. PV
85  2007 Genetic diseases of junctions. PKP
86  2007 IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus. NHK, PNP, PV
87  2007 Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis. PV
88  2007 Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3. ---
89  2007 Pemphigus vulgaris presenting in a radiation portal. ---
90  2007 Pemphigus vulgaris: recent advances in our understanding of its pathogenesis. AChR, Dsg3, PF, PV
91  2007 Targeting pemphigus autoantibodies through their heavy-chain variable region genes. PV
92  2008 Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission. ELISA, PF, PV
93  2008 B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses. ---
94  2008 Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature. PV
95  2008 Disease progression from mucosal to mucocutaneous involvement in a patient with desquamative gingivitis associated with pemphigus vulgaris. DG, ELISA, PV
96  2008 E-cadherin is an additional immunological target for pemphigus autoantibodies. FS, IP-IB, PF, PV
97  2008 Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay. ELISAs
98  2008 Expression of pemphigus-autoantigen desmoglein 1 in human thymus. ---
99  2008 IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris. EC, PV
100  2008 Neonatal pemphigus vulgaris. ---
101  2008 Orodigital pemphigus vulgaris: a pathogenic role of anti-desmoglein-3 autoantibodies in pemphigus paronychia? PV
102  2008 P120 catenin is associated with desmogleins when desmosomes are assembled in high-Ca2+ medium but not when disassembled in low-Ca2+ medium in DJM-1 cells. E-cad, p120ctn, PG
103  2008 P120-catenin is a novel desmoglein 3 interacting partner: identification of the p120-catenin association site of desmoglein 3. IA, p120ctn
104  2008 Pemphigus foliaceus. FS, PF, PV
105  2008 Pemphigus vulgaris and its active disease mouse model. PV
106  2008 Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. PF, PV
107  2008 Possible role of natural killer cells in pemphigus vulgaris - preliminary observations. IL, MHC, NK, PBL, PV
108  2008 Rituximab exerts a dual effect in pemphigus vulgaris. PV, Th
109  2008 Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high-dose immunoglobulin to prevent rebound increase in pathogenic IgG. DFPP, PV
110  2008 The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery. PG, STS
111  2009 A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris. ---
112  2009 Autoantibodies against desmocollins in European patients with pemphigus. Dsc, PNP, PV
113  2009 Clinical and immunological follow-up of pemphigus patients on adjuvant treatment with immunoadsorption or rituximab. IA, PV, RTX
114  2009 Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus. AFM, Dsc
115  2009 Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3. CTLA-4, FACS, GITR, IL, PV, TCR, TGF, Tr1
116  2009 Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies. Dsc, PV
117  2009 Lesions of pemphigus vulgaris on irradiated skin. PV
118  2009 Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor. EGF, EGFR, PV
119  2009 Pemphigus: the promises of peptide immunotherapy. ---
120  2009 Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus. PV, TP
121  2009 Protein kinase C isoenzymes differentially regulate the differentiation-dependent expression of adhesion molecules in human epidermal keratinocytes. PKC
122  2009 The molecular logic of pemphigus and impetigo: the desmoglein story. ---
123  2009 Update on the cloning of monoclonal anti-desmoglein antibodies from human pemphigus patients: implications for targeted therapy. mAbs, PF
124  2010 Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris. CNF1, FRAP, PV-IgG
125  2010 Autoimmune and infectious skin diseases that target desmogleins. Dsc, ET
126  2010 Binding of pemphigus vulgaris IgG to antigens in desmosome core domains excludes immune complexes rather than directly splitting desmosomes. DPK, PV
127  2010 Expression analysis of desmosomal components of the novel canine epidermal keratinocyte cell line (MSCEK). ---
128  2010 Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies. Ig
129  2010 Immune dysregulation of pemphigus in humans and mice. Ig
130  2010 Immune response towards the amino-terminus of desmoglein 1 prevails across different activity stages in nonendemic pemphigus foliaceus. EC, PF
131  2010 Immunopathologic features of pemphigus in the east Mediterranean region of Turkey: a prospective study. CAS, DIF, ELISA, IF, IIF, PV
132  2010 Induction of hyper-adhesion attenuates autoimmune-induced keratinocyte cell-cell detachment and processing of adhesion molecules via mechanisms that involve PKC. CAR, PV
133  2010 Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. PF, PV
134  2010 Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype. PH
135  2010 Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies. PV
136  2010 Removal of amino-terminal extracellular domains of desmoglein 1 by staphylococcal exfoliative toxin is sufficient to initiate epidermal blister formation. Dsc1-N, ETs
137  2010 Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity. ELISA, PV
138  2011 IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. PF, PV
139  2011 p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris. PV
140  2011 Retinoid Induces the Degradation of Corneodesmosomes and Downregulation of Corneodesmosomal Cadherins: Implications on the Mechanism of Retinoid-induced Desquamation. CDSN, Dsc, KLK, RA
141  2011 Staphylococcus pseudintermedius exfoliative toxin EXI selectively digests canine desmoglein 1 and causes subcorneal clefts in canine epidermis. exi
142  2011 The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting? PV
143  2012 Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy. IVIG, LTR, PV, RTX
144  2012 Desmosomal cadherins in zebrafish epiboly and gastrulation. DCs, Dsc, hpf
145  2012 Enrichment of total serum IgG4 in patients with pemphigus. PF, PV
146  2012 Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface. EC1, PV
147  2012 Ultrastructure of acantholysis in pemphigus foliaceus re-examined from the current perspective. PF
148  2013 Clinical and immunological profile of umbilical involvement in pemphigus vulgaris and pemphigus foliaceus. PF, PV
149  2013 Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion. Dsc, PV
150  2013 E-cadherin autoantibody profile in patients with pemphigus vulgaris. ELISAs, IP-WB, mcPV, mPV, PV
151  2013 Ectopic expression of epidermal antigens renders the lung a target organ in paraneoplastic pemphigus. PNP
152  2013 Endemic pemphigus foliaceus in the Peruvian Amazon. EPF, IIF
153  2013 Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study. ELISA
154  2013 IgA pemphigus with paraneoplastic pemphigus-like clinical features showing IgA antibodies to desmoglein 1/3 and desmocollin 3, and IgG and IgA antibodies to the basement membrane zone. Dsc
155  2013 Neural nitric oxide synthase participates in pemphigus vulgaris acantholysis through upregulation of Rous sarcoma, mammalian target of rapamycin and focal adhesion kinase. EGFR, FAK, mTOR, nNOS, NO, PV
156  2013 p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity. p38 MAPK, PF, PV
157  2013 The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies. ELISA, PF, PV
158  2013 Two cases of pemphigus vegetans with IgG anti-desmocollin 3 antibodies. cDNA, Dscs, ELISAs
159  2014 A desmoplakin point mutation with enhanced keratin association ameliorates pemphigus vulgaris autoantibody-mediated loss of cell cohesion. DP, PKC, PV
160  2014 Adducin is required for desmosomal cohesion in keratinocytes. PV
161  2014 Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study. ELISAs
162  2014 Desmosomal cadherins and signaling: lessons from autoimmune disease. ---
163  2014 Different roles of cadherins in the assembly and structural integrity of the desmosome complex. Dsc
164  2014 Insights into desmosome biology from inherited human skin disease and cardiocutaneous syndromes. ---
165  2014 Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus. PF, PV
166  2014 Nanorobotic investigation identifies novel visual, structural and functional correlates of autoimmune pathology in a blistering skin disease model. ---
167  2014 Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins. PF, PV
168  2015 Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests. ELISA, Ig, PV
169  2015 Immune cellular regulation on autoantibody production in pemphigus. ---
170  2015 Loss of Desmoglein Binding Is Not Sufficient for Keratinocyte Dissociation in Pemphigus. AFM, beta-MCD, PV
171  2015 Low pathogenicity of anti-desmoglein 3 immunoglobulin G autoantibodies contributes to the atypical clinical phenotypes in pemphigus. cPV, Ig
172  2015 Mucosal pemphigus vulgaris anti-Dsg3 IgG is pathogenic to the oral mucosa of humanized Dsg3 mice. hDSG3, IF, mcPV, mDsg3, PV, WT
173  2015 Oral lichen planus with antibodies to desmogleins 1 and 3. ELISA, LP
174  2015 Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris. PARP, PV
175  2015 Sgk1 regulates desmoglein 1 expression levels in oligodendrocytes in the mouse corpus callosum after chronic stress exposure. DSC1, Ndrg1
176  2015 Simultaneous immunolocalization of desmoglein 3 and IgG4 in oral pemphigus vulgaris: IgG4 predominant autoantibodies in its pathogenesis. PV
177  2015 Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity. ELISA, IIF, PF, PV, ROC
178  2016 Analyses of Gingival Adhesion Molecules in Periodontitis: Theoretical In Silico, Comparative In Vivo, and Explanatory In Vitro Models. Dsc, HNP-1, OCLN
179  2016 Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages. EC, EDTA, ELISA, PF, PV
180  2016 Family study of monozygotic twins affected by pemphigus vulgaris. PV
181  2016 Immune response in pemphigus and beyond: progresses and emerging concepts. HLA, PF, PV
182  2016 Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus. APC, autoAb, MG, Tfh, Th
183  2016 Increased oxidative stress in pemphigus vulgaris is related to disease activity and HLA-association. BP, PV, TAC
184  2016 Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology. KCs
185  2016 Multiplexed autoantigen microarrays identify HLA as a key driver of anti-desmoglein and -non-desmoglein reactivities in pemphigus. autoAbs, PV
186  2016 Nuclear magnetic resonance titration of the interaction between pemphigus vulgaris autoantibodies and REWVKFAKPCRE, a therapeutic desmoglein 3 peptide. NMR, PV
187  2016 Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris. EC, mAbs, PV
188  2016 Pemphigus with features of both vulgaris and foliaceus variants localized to the nose. ---
189  2016 Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. BCR, CAAR, PV
190  2016 Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris. ELISA, PV
191  2016 Two cases of erosive oral lichen planus with autoantibodies to desmoglein 3. ELISA, erosive OLP, IF, Ig, OLP, PV
192  2017 Analysis of immunological profile, clinical features and response to treatment in pemphigus. ---
193  2017 Conjunctiva derived mesenchymal stem cell (CJMSCs) as a potential platform for differentiation into corneal epithelial cells on bioengineered electrospun scaffolds. CJMSCs, CK, Dsc, ICC, PU
194  2017 Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus. PF, PV
195  2017 Divergent Specificity Development of IgG1 and IgG4 Autoantibodies in Endemic Pemphigus Foliaceus (Fogo Selvagem). FS
196  2017 Inhibition of p38MAPK signalling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis. p38 MAPK, PV
197  2018 Atomic Force Microscopy Provides New Mechanistic Insights into the Pathogenesis of Pemphigus. AFM
198  2018 Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury. CD, Dsc, DSS
199  2018 Desmogleins as signaling hubs regulating cell cohesion and tissue/organ function in skin and heart - EFEM lecture 2018. AC
200  2018 Diagnosis of autoimmune bullous diseases. AIBDs, IF
201  2018 Diagnostik blasenbildender Autoimmundermatosen. BAIDs, IF-Mikroskopie
202  2018 E-cadherin binds to desmoglein to facilitate desmosome assembly. Dsc, E-cad
203  2018 Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice. PV
204  2018 Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris. CK-1, PV
205  2018 Keratins Regulate p38MAPK-Dependent Desmoglein Binding Properties in Pemphigus. Ab, KtyII k.o, PF, WT
206  2018 Keratins Regulate the Adhesive Properties of Desmosomal Cadherins through Signaling. ---
207  2018 New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature. DIF, ELISA, IIF, PF, PV
208  2018 Ultrastructural changes in endometrial desmosomes of desmoglein 2 mutant mice. Dsc, Dsp
209  2019 A potential link between desmoglein 3 and epidermal growth factor receptor in oral squamous cell carcinoma and its effect on cetuximab treatment efficacy. EGFR, OSCC
210  2019 Herpetiform pemphigus with characteristic transmission electron microscopic findings of various-sized ballooning vacuoles in keratinocytes without acantholysis. HP, TEM
211  2019 Plakophilin 1 but not plakophilin 3 regulates desmoglein clustering. AFM, Pkp, WT
212  2019 Role of Src and Cortactin in Pemphigus Skin Blistering. PV, WT